Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating autologous cytotoxic T lymphocytes for BK virus and JC virus infections in immunocompromised patients (including AIDS/HIV context) with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cytotoxic T lymphocytes (cytotoxic T lymphocytes)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acquired Immunodeficiency Syndrome, BK Virus Infection | Phase 2 | Status: RECRUITING